At 5.8% CAGR Enteral Nutrition Market To Reach US$ 3,903.7 Million By 2027


Enteral nutrition, also known as tube feeding, refers to any method of feeding that uses the gastrointestinal (GI) tract to deliver caloric requirements, including normal oral diet or liquid supplements. Nasoenteral, also known as nasogastric tube feeding, involves inserting a tube in the stomach through the nose. Whereas, a jejunostomy tube is placed directly through the skin. The tube feeding formula is used in patients suffering from chronic conditions including head trauma, cancer, and strokes. Moreover, the formula helps premature infants to gain required nutrition and medications. According to the National Center for Biotechnology Information (NCBI), nasogastric tubes are the most preferred method for short term feeding in the acute phase of stroke and are commonly used for providing nutrition, hydration, and essential medications.

For Any Queries Get Solutions With PDF Sample: https://www.coherentmarketinsights.com/insight/request-sample/1115

Major factors propelling growth of the global enteral nutrition market are rising prevalence of chronic diseases such as diabetes, heart disease, and cancer, coupled with increasing health care expenditure across the globe. According to the American Diabetes Association (ADA), long term use of nutritional support with diabetes-specific formula helps in reducing chronic complications of diabetes such as cardiovascular diseases. According to the National Center for Biotechnology Information (NCBI), the use of enteral nutrition is helpful in patients with chronic heart failure (CHF). Furthermore, according to the Office for National Statistics, in the U.K., total health care expenditure was US$ 239.92 billion in 2014, which increased by 3.6% to US$ 248.51 billion in 2015. High health care expenditure of a region explains the affordability of expensive medical services. This in turn, is expected to support the overall growth of the enteral nutrition market as tube feeding is costlier compared to feeding without tubes. Enteral nutrition is used for patients across all age groups, however, the geriatric population segment is the most lucrative segment. Health concerns such as metabolic disorders and loss of appetite are more prevalent among the geriatric population, therefore, the growing geriatric population across the globe is projected to facilitate the market growth.

Complications associated with enteral nutrition include patient safety risks and feeding and medication errors. These are expected restrain growth of this market growth. For instance, according to the NCBI, placing a nasogastric tube can lead to various health problems such as gastrointestinal complications, aspiration, mechanical complications, and metabolic complications.

Quick Buy – Enteral Nutrition Market Research Report: https://www.coherentmarketinsights.com/insight/buy-now/1115

North America dominated the enteral nutrition market in 2016, and accounted for over 30% of the market share. The market is expected to retain its dominance throughout the forecast period (2017–2025). The increasing geriatric population in the region, coupled with the rising incidence of chronic illnesses are some of the factors complementing growth of the enteral nutrition market in North America. According to the Centers for Disease Control and Prevention (CDC), heart diseases, cancer, diabetes and strokes were the leading causes of disability and death in the U.S. in 2016. Moreover, according to the National Cancer Institute, in 2016, around 1.6 million patients were diagnosed with cancer in the U.S., out of which 0.59 million died from the disease. These factors are responsible for increased use of enteral nutrition in the U.S., thereby fuelling growth of the market in North America.

Asia Pacific is projected to be the fastest growing market for enteral nutrition, and exhibit a CAGR of 6.35% over the forecast period with India and China accounting for major market share. China and India have high proportion of geriatric population. According to the United Nations Economic and Social Commission for Asia and Pacific (UNESCAP), the geriatric population in Asia Pacific is rising significantly. In 2016, the proportion of geriatric population in North East Asia was around 17%, which is expected to cross 35%. Whereas, in North and Central Asia it is projected to cross 20% by 2050. Furthermore, diabetes has become a major health concern in this region.

According to data provided by the National Center for Biotechnology Information (NCBI), in 2014, the region accounted for around 150 million diabetic patients, out of which, over 95% had type 2 diabetes (T2DM). Furthermore, according to the World Health Organization (WHO), in 2016, China had a high diabetic population of around 110 million and the number is expected to increase to 150 million by 2040. However, China’s healthcare spending has increased significantly over the past decade, from US$ 90.8 billion in 2004 to US$ 590.2 billion in 2014 and it is expected to increase further. The growing healthcare expenditure is expected to boost the market growth. These factors are expected to strongly support growth of the enteral nutrition market in Asia Pacific in the near future.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/global-enteral-nutrition-market-to-surpass-us-1931-billion-by-2025-511

Among disease type, chronic segment accounted for the largest market share in 2016 and is expected to retain its dominance throughout the forecast period. The rising number of chronic diseases such as cancer, cardiovascular diseases, and diabetes worldwide is propelling demand for enteral nutrition. According to the World Health Organization (WHO), in 2015, out of 56.4 million global deaths, around 70% were due to non-communicable diseases (NCDs), which include cardiovascular diseases, diabetes, cancer, and chronic lung diseases.

Among age groups, the above 60 segment accounted for the largest market share in 2016, and is expected to be the fastest growing segment. According to the Department of Economic and Social Affairs Population Division, the geriatric population (aged 60 or above) is expected to increase by 56% between 2015 and 2030. According to the NCBI, spending on healthcare services for the elderly population has been increasing since 1965. These are the major factors, which are expected to support growth of the enteral nutrition market over the forecast period.

Major players operating in the global enteral nutrition market include Nestle S.A., Baxter International Inc., B. Braun Holding GmbH & Co. KG, Abbott Laboratories, Groupe Danone, Reckitt Benckiser Group Plc, Perrigo Company Plc., Meiji Seika Pharma Co. Ltd., and Fresenius Kabi AG.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Nutrition Type
      • Market Snippet, By Formulation
      • Market Snippet, By Patient Type
      • Market Snippet, By Application
      • Market Snippet, By Distribution Channel
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Regulatory Scenario, By Country
    • Reimbursement Scenario, By Country
    • Key Developments
    • PEST Analysis
    • List of Contract Manufacturers
    • Mergers, Acquisitions and Collaboration Scenario
    • Product Launch/Approvals
    • Market Trends
    • Major Brand Analysis
    • Epidemiology
    • Value Chain Analysis/Product Journey
  4. Global Enteral Nutrition Market – Impact of Coronavirus (Covid-19) Pandemic
    • Economic Impact
    • Research and Development
    • Government Measures to combat COVID-19
    • COVID-19 Epidemiology
  5. Global Enteral Nutrition Market, By Product Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Standard Enteral Nutrition
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Enteral Nutrition for Chronic Illness
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Enteral Nutrition Market, By Nutrition Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Proteins
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Carbohydrates
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Multi-vitamins and Antioxidants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Amino Acid
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Fibers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Minerals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Enteral Nutrition Market, By Formulation, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Powder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Liquid
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Global Enteral Nutrition Market, By Patient Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Infant (1 month to 2 years)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Children (2 to 12 years)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Adolescent & Adult (12 to 65 years)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Geriatric (>65 years)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Chronic Patient (Excluding all above in all age groups)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  9. Global Enteral Nutrition Market, By Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Gastrointestinal Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Diabetes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Critical Care
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  10. Global Enteral Nutrition Market, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • E-commerce
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  11. Global Enteral Nutrition Market, By End User, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Home Care Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Retirement Homes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  12. Global Enteral Nutrition Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Nutrition Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Formulation, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Patient Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Nutrition Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Formulation, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Patient Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Argentina
        • Mexico
        • Colombia
        • Peru
        • Rest of Latin America
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Nutrition Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Formulation, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Patient Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Japan
        • China
        • South Korea
        • Vietnam
        • Philippines
        • India
        • Thailand
        • Indonesia
        • Malaysia
        • Australia
        • Taiwan
        • Rest of Asia Pacific
    • Europe, Middle East, and Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Nutrition Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Formulation, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Patient Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • France
        • Italy
        • U.K.
        • Netherlands
        • Spain
        • Saudi Arabia
        • Russia
        • Egypt
        • South Africa
        • Turkey
        • Sweden
        • Rest of Europe, Middle East and Africa
  13. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Analyst Views
  14. Section
    • References
    • Research Methodology
    • About us and Sales Contact

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Leave a Reply

Your email address will not be published. Required fields are marked *